This is a routine annual compliance filing with no new financial data or material events. Monitor the next 6-K or 20-F for actual financial results and guidance.
Price Chart
Executive Summary
Clinuvel Pharmaceuticals filed its annual report, corporate governance disclosures, and investor presentation with the ASX via a 6-K. The filing is a routine annual compliance update for a foreign private issuer; no specific financial figures, guidance changes, or material events were extractable from the provided document text. The filing is neutral with no actionable trading signal.
Key Facts
- Filed annual report (Ex-99.1), corporate governance disclosure (Ex-99.2), Appendix 4G (Ex-99.3), investor presentation (Ex-99.4), and three press releases (Ex-99.5, 99.6, 99.7) with the ASX.
- Filing is a routine 6-K submission of documents already filed in the company's home market (Australia).
- No financial results, guidance, or material corporate events were identifiable from the filing text provided.
Financial Impact
No financial data available in the filing text.
Risk Factors
- No specific risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-040352 |
| Document: 0001493152-26-040352-index-headers.html | 0001493152-26-040352 |
| Document: 0001493152-26-040352-index.html | 0001493152-26-040352 |
| Document: 0001493152-26-040352.txt | 0001493152-26-040352 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 6-K | $5.06 | awaiting T+20 | — | $4.94 (−2.37%) |
Oct 7, 2026 19d ago | 6-K | $5.80 | awaiting T+20 | — | $4.94 (−14.83%) |
Oct 2, 2026 24d ago | 6-K | $6.03 | awaiting T+20 | — | $4.94 (−18.08%) |
Oct 1, 2026 25d ago | 6-K | $5.66 | awaiting T+20 | — | $4.94 (−12.72%) |
Aug 27, 2026 8w ago | 6-K | $6.77 $5.78 | ▼ −14.62% | ▼ −14.12% | $4.94 (−27.03%) |
Aug 27, 2026 8w ago | Press Release | $6.77 $5.78 | ▼ −14.62% | ▼ −14.12% | $4.94 (−27.03%) |
Aug 20, 2026 9w ago | 6-K | $7.80 $5.90 | ▼ −24.36% | ▼ −24.36% | $4.94 (−36.67%) |
Jul 23, 2026 13w ago | 6-K | $6.95 $7.80 | ▲ +12.23% | ▲ +8.92% | $4.94 (−28.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers